Shanghai Shen Lian Biomedical Corporation (SHSE: 688098)
Health Care · Pharmaceuticals · CN
CN¥8.32
-1.65% today · -20.5% 1Y
Shanghai Shen Lian Biomedical Corporation (SHSE: 688098) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $510.08M and employs 375 people.
Over the last twelve months the share price has lost 20.5%, trading between 7.29 and 12.36.
Tweenvest scores Shanghai Shen Lian Biomedical Corporation across four factors: quality 74/100, value 59/100, growth 0/100. Its strongest factor is quality.
688098 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $510.08M
- Revenue (TTM)
- $40.99M
- P/E
- —
- EPS
- -0.07
- Dividend yield
- —
- Beta (5Y)
- 0.53
- 52-week high
- CN¥12.36
- 52-week low
- CN¥7.29
- Avg volume (3M)
- —
- Shares outstanding
- 410.64M
- Employees
- 375
- Next earnings
- —
About Shanghai Shen Lian Biomedical Corporation
Shanghai Shen Lian Biomedical Corporation operates within China's animal health industry, specializing in the entire lifecycle of veterinary biological products, from initial research and development to manufacturing and sales. A primary focus for the company is the creation of advanced synthetic peptide vaccines, specifically engineered to combat foot-and-mouth disease. This enterprise was established in 2001 and is based in Shanghai, China.
- ISIN
- CNE100003P17
- Founded
- 2001
- Listed since
- Oct 28, 2019
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Orchid Pharma LimitedNSEI: ORCHPHARMA | $515.65M | Rs983.95 | -0.61% |
| Oculis Holding AGNasdaqGM: OCS | $514.85M | $8.34 | -3.70% |
| Evolus, Inc.NasdaqGM: EOLS | $510.57M | $7.73 | -0.90% |
| Synmosa Biopharma CorporationTPEX: 4114 | $510.24M | NT$30.15 | +2.73% |
| Shaanxi Kanghui Pharmaceutical Co., Ltd.SHSE: 603139 | $507.15M | CN¥34.01 | -0.50% |
| PKU HealthCare Corp.,Ltd.SZSE: 000788 | $504.51M | CN¥5.67 | +3.85% |
| Contineum Therapeutics, Inc.NasdaqGS: CTNM | $503.37M | $13.38 | +1.52% |
| Tibet AIM Pharm. Inc.SZSE: 002826 | $501.71M | CN¥17.68 | +0.51% |
Figures last refreshed Oct 11, 2026.